Markers of Bone Destruction and Oxidative Stress in Peri-implantitis
Official title: Evaluation of Bone Destruction and Oxidative Stress Markers in Saliva and Peri-implant Sulcus Fluid in Peri-implantitis
Run by Saglik Bilimleri Universitesi · NCT07397884 · Data updated 2026-11-12
This study tests whether saliva and peri-implant sulcular fluid reflect bone loss and inflammation in peri-implantitis, periodontitis, and healthy teeth to help with early detection.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Saglik Bilimleri Universitesi Academic / other |
| Locations | 1 site (Keçiören, Ankara) |
| Status | Recruiting |
| Started | February 15, 2026 |
| Main results expected | November 15, 2026 |
| Study ends | November 20, 2026 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT07397884 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Systemically healthy adults aged 18–65 with peri-implantitis, periodontitis, or healthy implants/teeth meeting the respective inclusion criteria.
✕Probably not a fit
Patients without peri-implantitis or periodontitis or those whose biomarkers do not correlate with disease status may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will compare biomarkers of bone resorption (RANKL, OPG), oxidative stress (nitrotyrosine, NQO1), and a pro-inflammatory cytokine (IL-1β) in saliva and peri-implant sulcular fluid across four groups: peri-implantitis, periodontitis, and healthy peri-implant and periodontal sites. Participants will be 18–65 years old and categorized based on clinical and radiographic criteria. Samples will be collected under standardized conditions, with clinical parameters (PI, GI, BOP, PD, CAL) recorded at six sites per tooth or implant. Analyses will aim to determine the diagnostic value of these biomarkers for early detection and progression of peri-implant diseases.
Why it matters
Potential benefit: If successful, biomarkers could improve early detection and monitoring of peri-implant disease risk and progression.
How similar studies have gone: Previous research has shown associations between inflammatory and oxidative stress markers and periodontal diseases; this study adds peri-implant contexts and direct comparisons.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Systemically healthy volunteers aged 18-65. For Peri-implantitis group: Implants in function for ≥1 year, radiographic bone loss ≥ 2 mm, probing depth (PD) ≥ 5 mm, and presence of bleeding on probing (BOP) or suppuration. For Periodontitis group: At least one tooth with PD ≥ 4 mm, presence of BOP, and radiographic bone loss.For Healthy groups: PD ≤ 3 mm, no clinical inflammation (BOP-), and no radiographic bone loss. (According to the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases) - Exclusion Criteria:Presence of systemic diseases (e.g., diabetes, rheumatoid arthritis, osteoporosis). Use of antibiotics, anti-inflammatory, or immunosuppressive drugs within the last 3 months. Pregnancy or breastfeeding. Smoking (current smokers). History of periodontal or peri-implant surgical treatment within the last 6 months. Implant failure (mobility). Signs of acute infection (fever, systemic symptoms). \-
Where it's running
-
Gülhane Faculty of Dentistry, University of Health Sciences
Keçiören, Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Gülbahar Ustaoğlu, Professor — University of Health Sciences, Gulhane Faculty of Dentistry, Department of Periodontology
- Study coordinator: Nurullah Yurdakul, Dr.
- Email: nurullah.yurdakul@sbu.edu.tr
- Phone: +905340757662
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease
This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.
-
Bacterial Diversity in Gum Health With Fixed vs Removable Retainers After Braces
This study tests the gum microbiome and gum health in adults after braces, comparing fixed lingual retainers to removable Essix retainers.
-
Hyperuricemia and gum disease: is uric acid linked to bone loss in periodontitis?
This observational study tests whether high uric acid levels are related to periodontitis and alveolar bone loss in adults.
-
See if periodontal treatment improves chewing ability and oral quality of life
This study tests whether treating periodontitis improves how well people can chew and how they feel about their oral health.
-
Vitamin D and the body's anti-inflammatory response in gum disease
This study tests whether vitamin D can modulate the body's anti-inflammatory response in people with gum disease.
-
Candida albicans and periodontitis in Syrian patients
This project will test whether Candida albicans is commonly present in the gum pockets of Syrian adults with chronic periodontitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.